Schedule 13D ownership disclosure
Phathom Pharmaceuticals Inc
Security class unavailable · CUSIP: 71722W107
Event date: 2024-01-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,755,583
- Percent of class
- 6.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001395064-24-000006
- Form type
- SC 13D
- Filer
- Phathom Pharmaceuticals, Inc.
- CIK
- CIK 1783183
- Filed
- Jan 25, 2024
- Reporting period
- Jan 24, 2024
- Description
- Schedule 13D beneficial ownership